Kuros Biosciences delivers 45% H1 2026 year-over-year sales growth and increases overall profitability
Kuros Biosciences (“Kuros” or the “Company”) a leader in next generation bone healing technologies, today announced its…
Kuros Biosciences AG
Kuros Biosciences to showcase MagnetOs™ commercial momentum and plan for scalable quality growth at Capital Markets Day in Zürich
Kuros Biosciences (“Kuros” or the “Company”) a leader in innovative biologic technologies, is pleased to announce today’…
Kuros Biosciences appoints I.V. Hall as Chief Operating Officer, deepening operational, R&D and extremities leadership for next phase of growth
Kuros Biosciences (“Kuros” or the “Company”) a leader in next generation bone healing technologies, today announced the…
Annual General Meeting of Kuros Biosciences approves all resolutions
Kuros Biosciences (“Kuros” or the “Company”) a leader in next generation bone healing technologies, held its Annual Gene…
Kuros Biosciences reports 51% year-over-year increase in sales in the first three months of 2026
Financial Highlights Total product sales rose by 51% to USD 43.4 million (Q1 2025: USD 28.8 million) Direct MagnetO…
Kuros Biosciences delivers 72% year-over-year sales growth, reaching USD 146.1 million for 2025
Ad-hoc announcement pursuant to Article 53 of the SIX listing rules Financial Highlights Total Medical Device sales r…
Kuros Biosciences to provide investor update at Octavian and Baader Bank Conferences
Kuros Biosciences (“Kuros” or the “Company”) a leader in innovative biologic technologies, today announced a series of m…
Kuros Biosciences announces enrollment of first patient in ASTRA study
Kuros Biosciences (“Kuros” or the “Company”) a leader in innovative biologic technologies, today announced that the firs…
Kuros Biosciences to present at the Piper Sandler 37th Annual Healthcare Conference
Kuros Biosciences (“Kuros” or the “Company”) a leader in innovative biologic technologies, will present at the Piper San…
Kuros Biosciences increases the annual guidance for 2025
Financial & Operational Highlights Total Medical Device sales rose by 77% to USD 101.1 million for the first nine m…
